The effects of warmed fluid therapy on medetomidine (MED)-induced hypothermia in normal dogs were evaluated. Animals were intramuscularly administered physiological saline solution (control) or 40 μg/kg of MED. At the same time, each treated dogs were intravenously administered 10 ml/kg/hr of Ringer's solutions at room temperature (RT) or after warming the fluids with either Animec (ANI) or Medi-Temp (MEDI) for 4 hours. In the MED-ANI group, the tendency to normalize hypothermia was observed, but no significant differences were recorded in rectal temperature between the MED-ANI and MED-RT groups. The results did not significantly support the reduction in MEDinduced hypothermia by warmed fluids. 
Introduction
Medetomidine (MED) is a widely used a sedative agent in veterinary practice, but has been reported to induce severe hypothermia. Many studies suggest that attempts should be made to conserve body heat and prevent marked reductions in body temperature [6] [7] [8] .
Therefore, we investigated the effect of administering warmed fluids. The effect of warmed fluid therapy has been minimally reported in human medicine 4, 10) . Fluid-warming equipment for veterinary use is also commercially available. To the author's knowledge, there have been no reports on the effectiveness of administration of warmed fluids for the treatment of hypothermia in veterinary medicine, even though warmed fluid effectiveness has been described in some textbooks 2, 3) . The purpose of this study was to investigate the effects of intravenous administration 
Materials and Methods
The subjects included in this study were five clinically normal beagle dogs (two intact and three neutered males), aged 5.4 ± 0.5 years (mean ± S.D.), with a body weight of 14.2 ± 1.2 kg (mean ± S.D.). All dogs were standard figure. This experiment was approved by the Animal Research Committee of Kurashiki University of Science and the Arts, Okayama, Japan (No. 21-26).
Two types of fluid-warming equipment were used.
The Animal Fluid Warmer (ANIMEC AM-2S; ELLTEC Co. Ltd., Nagoya, Japan) is an electrically powered warmer consisting of a dry heating plate that supplies heat to the infusion-or blood-tubing set (will be referred to as ANI in this report). The temperature setting is fixed at 37°C and cannot be changed by the user. Temperature sensors in contact with the tubing control heat and regulate temperature. The second equipment was a blood-and fluid-warming unit (Medi-Temp III FW600; Gaymer Industries Inc., NY, USA) that was also made of a dry heating system (will be referred to as Medi-Temp in this report). This device is placed on a cassette for standard flow (Medi-Temp III Standard Set; Gaymer Industries Inc., NY, USA), and the temperature of the fluid can be adjusted from 38°C to 43°C in one-degree increments so that it can be used for a wide range of procedures. Owing to the design of each equipment, the length of the tube from the device to the animal was not same. In our study, the length of each ANIMEC tube was 30 cm, and each Medi-Temp was 127 cm.
The experiment was divided into six sets, and the five beagle dogs were repeatedly used, by following a randomised block design. There was at least 1 week between treatments for each dog. Treatment involved intramuscular administration of 1. 
Results
In the control groups, the rectal temperature decreased slightly during fluid administration for 4 hr in all the dogs RT group. At 2 to 7 hr after MED administration, the rectal temperature of the MED-ANI group tended to be maintained higher than that of the MED-RT group by 0.5°C, but there were no significant differences in rectal temperatures between the MED groups. There were no significant differences in the heart rates between the MED groups, but bradycardia was observed after MED administration in all the MED groups ( Table   1 ). The heart rates were significantly different only at 6 hr after administration between the control-RT and -ANI groups.
No significant changes in respiratory parameters were observed between any of the control groups (Table 2) . At 3 hr after MED administration, the respiratory rate significantly decreased in all the MED groups (P<0.05).
There were no significant differences in the respiratory rates between the MED groups. In all the control and MED groups, no significant changes were recorded in the mean, systolic, and diastolic blood pressure. In all MED-ANI and -MEDI groups, however, the tendency of transient increase followed by decrease was observed in mean, systolic, and diastolic blood pressure.
In all MED treated groups, each sedative duration 
Discussion
In this study, a decrease in rectal temperature was observed in all dogs treated with MED, which is consistent with previous reports 7, 8) . And, the lowest rectal temperature was recorded at 4 hr after MED administration. This tendency was not observed in control groups although the decrease in rectal temperature was also shown. This changes of rectal temperature was considered to be characteristic of MEDinduced hypothermia. This is the first observation of medetomidine-induced hypothermia for such long duration, as far as authors know. Similar to rectal temperature, the decreases of heart rate and respiratory rate were also observed obviously for 2 to 4 hr in this study. Additionally, it was also reported that the effects of medetomidine on insulin secretion and other endocrine functions sustained for 2 hr or more after administration 1) . Thus, duration of these physiological changes induced by medetomidine was longer compared with that of sedative effect. The decrease in rectal As mentioned in results, the heart rates were significantly different at 6 hr after administration between the control-RT and -ANI groups. However, we could not reveal that reason. On the other hand, we did not observe any siginificant transient increase or sustained decrease in the blood pressure in the dogs after MED administration. It was different from the previous report 8) . Thus, the effect of warmed fluid administration on blood pressure in dogs treated with MED has not been discussed.
The change in rectal temperature was not greater than 1°C in all the control groups; however, some significant decreases were observed. Therefore, the administration of warmed fluids to normal dogs without MED treatment, using the commercially available methods, does not clinically affect their rectal temperature. The results suggest that the use of ANI or MEDI does not induced hyperthermia compared to administration at RT. This study showed that warmed fluid therapy results in clinically insignificant changes in rectal temperature only. The possibility of using warmed fluid therapy should be seriously considered, and a more detailed investigation is necessary to confirm this.
